ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 928,66
-0,70%
Dow Jones
38 090,39
0,49%
DAX
17 910,47
-0,06%
Brent Oil
83,105
-0,52%
Bitcoin
59 129,91
1,53%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cassava Sciences Inc (SAVA)

  7. Cassava Sciences Inc (SAVA) Actualités

SAVA Cassava Sciences Inc

22,035
-0,105 (-0,47%)
Dernière mise à jour : 16:48:44
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Cassava Sciences Inc SAVA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,105 -0,47% 22,035 16:48:44
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
22,20 21,95 22,25 22,14
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202415:10GLOBETomorrow is Last Day to Trade SAVAW Warrants on NASDAQ
15/4/202415:20GLOBERedemption Date Announced for Warrants
25/3/202414:13GLOBECassava Sciences Announces Completion of an Interim Safety..
04/3/202415:15GLOBECassava Sciences Announces Virtual Presentation at the..
28/2/202422:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202415:22EDGAR2Form 8-K - Current report
28/2/202415:14GLOBECassava Sciences Reports Full-year 2023 Financial Results..
07/2/202415:20EDGAR2Form 8-K - Current report
07/2/202415:08GLOBENo Decline in Cognition Scores in Patients with Mild..
01/2/202422:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/1/202422:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/1/202415:12GLOBECassava Sciences Completes Dividend Distribution of Warrants..
03/1/202422:24EDGAR2Form CERT - Certification by an exchange approving..
03/1/202422:22EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
03/1/202422:18EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
03/1/202415:10EDGAR2Form 8-K - Current report
02/1/202415:10EDGAR2Form 8-A12G - Registration of securities [Section 12(g)]
12/12/202315:19EDGAR2Form 8-K - Current report
12/12/202315:13GLOBECassava Sciences Announces Dividend Distribution of Warrants..
11/12/202322:18EDGAR2Form 8-K - Current report
08/12/202323:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202322:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202322:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202322:01GLOBECassava Sciences Appoints Three New Members to its Board of..
07/11/202315:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202315:08EDGAR2Form 8-K - Current report
07/11/202315:01GLOBECassava Sciences Reports Third Quarter 2023 Financial and..
06/11/202315:15GLOBECassava Sciences Completes Enrollment for Pivotal Phase 3..
25/10/202315:15GLOBEMRI Data Suggest Simufilam is Not Associated with..
13/10/202315:06IHMARKETNEWSFriday’s Wall Street Highlights: Dollar General, Microsoft,..
13/10/202305:43GLOBEStatement by Cassava Sciences Regarding an Internal CUNY..
05/10/202315:15GLOBECassava Sciences to Present at the Jefferies Biotech..
05/10/202300:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202300:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202300:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202300:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202315:00GLOBECassava Sciences Completes Patient Enrollment for Pivotal..
18/9/202315:15GLOBECassava Sciences Announces Positive Interim Safety Review of..
13/9/202322:17EDGAR2Form 8-K - Current report
11/9/202315:10GLOBECassava Sciences Announces Science Publication That Confirms..
06/9/202315:15GLOBECassava Sciences Invited to Present in Four Upcoming..
24/8/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202322:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202322:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202315:12EDGAR2Form 8-K - Current report
03/8/202315:07GLOBECassava Sciences Reports Q2 2023 Financial Results and..
05/7/202315:25EDGAR2Form 8-K - Current report
05/7/202315:15GLOBEOral Simufilam Slowed Cognitive Decline in a Randomized..
27/6/202315:15GLOBENew Research Shows Simufilam Suppresses Overactive mTOR
12/6/202315:15GLOBENew Publication Highlights Basic Science Supporting..

Dernières Valeurs Consultées

NASDAQ
SAVA
Cassava Sciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés